Launch Date: June 6, 2022
Expiration Date: June 5, 2023
- Click here to take the mandatory pre-test before viewing the on-demand offering, which is required in order to receive CE credit.
- Click here to view the on-demand ‘Optimizing PrEP Access Through Advocacy’ offering from April 27, 2022.
- Click here to take the post-test and evaluation, which is required in order to receive CE credit.
This activity is jointly provided by Global Education Group and Integritas Communications.
This activity is supported by an educational grant from Gilead Sciences, Inc.
Activity Description
This activity will focus on medication therapy management protocols and their impact on prescription drug coverage policies. It also will look at PrEP access through a health equity lens and will include a review of the drug utilization review process, insurance models, and health impact analysis—considering the impact of each on patients and care.
Target Audience
The educational design of this activity addresses the needs of clinical and community pharmacists involved in the treatment of patients at risk for HIV infection as well as managed care pharmacists, pharmacy benefit managers, and specialty pharmacists.
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe how Medication Therapy Management (MTM) protocols impact prescription drug coverage policies, PrEP access, and health equity
- Review the basics of the Drug Utilization Review (DUR) process and its relationship to and impact on public and private insurance models
- Discuss how PrEP providers, practitioners, and advocates can participate in effective MTM protocols.
Faculty
Melissa Badowski, PharmD, MPH
Clinical Associate Professor, University of Illinois at Chicago, College of Pharmacy
Scott Bertani, MA
Director Of Advocacy, HealthHIV
Pharmacist Accreditation Statement
Credit Designation
Global Education Group designates this continuing education activity for 1.0 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education.
- Universal Activity Number: 0530-9999-22-035-H02-P
This is a knowledge-based activity.
Instructions to Receive Credit
You must watch the full webcast, pass the post-test with 70% or better, and submit a completed evaluation form to receive credit. CE credits will be uploaded to CPE Monitor within 60 days.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or [email protected].
Fee Information & Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosures of Conflicts of Interest
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
| Name of Faculty or Presenter | Reported Financial Relationship |
| Melissa Badowski, PharmD, M | Nothing to disclose |
| Scott Bertani, MA | Nothing to disclose |
The planners and managers have the following relevant financial relationships with ineligible companies:
| Name of Planner or Manager | Reported Financial Relationship |
| Lindsay Borvansky | Nothing to disclose |
| Andrea Funk | Nothing to disclose |
| Liddy Knight | Nothing to disclose |
| Ashley Cann | Nothing to disclose |
| Stacey Ullman, MHS | Nothing to disclose |
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Integritas Communications do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
